Ergoteles’s Fate Therapeutics FATE Stock Holding History

Ergoteles’s Portfolio FATE Stock Details FATE Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell
2023 Q2	$147K	Buy
2022 Q1	–	Sell
2021 Q4	$2.75M	Buy
2021 Q3	–	Sell
2021 Q2	$308K	Sell
2021 Q1	$1.59M	Buy